Generic Portal

APOE1 mutation in a patient with type III hyperlipoproteinaemia: detailed genetic analysis required

Visser, M. E., Dallinga-Thie, G. M., Pinto-Sietsma, S. J., Defesche, J. C., Stroes, E. S. & van der Valk, P. R., 2012, In: Netherlands journal of medicine. 70, 6, p. 278-280

Research output: Contribution to journal › Article › Academic › peer-review

Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial

Visser, M. E., Wagener, G., Baker, B. F., Geary, R. S., Donovan, J. M., Beuers, U. H. W., Nederveen, A. J., Verheij, J., Trip, M. D., Basart, D. C. G., Kastelein, J. J. P. & Stroes, E. S. G., 2012, In: European heart journal. 33, 9, p. 1142-1149

Research output: Contribution to journal › Article › Academic › peer-review

Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia

Surendran, R. P., Visser, M. E., Heemelaar, S., Wang, J., Peter, J., Defesche, J. C., Kuivenhoven, J. A., Hosseini, M., Péterfy, M., Kastelein, J. J. P., Johansen, C. T., Hegele, R. A., Stroes, E. S. G. & Dallinga-Thie, G. M., 2012, In: Journal of internal medicine. 272, 2, p. 185-196

Research output: Contribution to journal › Article › Academic › peer-review

An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia

Johansen, C. T., Wang, J., Lanktree, M. B., McIntyre, A. D., Ban, M. R., Martins, R. A., Kennedy, B. A., Hassell, R. G., Visser, M. E., Schwartz, S. M., Voight, B. F., Elosua, R., Salomaa, V., O'Donnell, C. J., Dallinga-Thie, G. M., Anand, S. S., Yusuf, S., Huff, M. W., Kathiresan, S., Cao, H., & 1 othersHegele, R. A., 2011, In: Arteriosclerosis, thrombosis, and vascular biology. 31, 8, p. 1916-1926

Research output: Contribution to journal › Article › Academic › peer-review

Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C)

Visser, M. E., Kropman, E., Kranendonk, M. E., Koppen, A., Hamers, N., Stroes, E. S., Kalkhoven, E. & Monajemi, H., 2011, In: Diabetologia. 54, 7, p. 1639-1644

Research output: Contribution to journal › Article › Academic › peer-review

Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia

Visser, M. E., Lammers, N. M., Nederveen, A. J., van der Graaf, M., Heerschap, A., Ackermans, M. T., Sauerwein, H. P., Stroes, E. S. & Serlie, M. J., 2011, In: Diabetologia. 54, 8, p. 2113-2121

Research output: Contribution to journal › Article › Academic › peer-review

Apolipoprotein B synthesis inhibition: results from clinical trials

Visser, M. E., Kastelein, J. J. & Stroes, E. S., 2010, In: Current opinion in lipidology. 21, 4, p. 319-323

Research output: Contribution to journal › Review article › Academic › peer-review

Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemia

Visser, M. E., Akdim, F., Tribble, D. L., Nederveen, A. J., Kwoh, T. J., Kastelein, J. J. P., Trip, M. D. & Stroes, E. S. G., 2010, In: Journal of lipid research. 51, 5, p. 1057-1062

Research output: Contribution to journal › Article › Academic › peer-review

Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholesterol in Patients With Familial Hypercholesterolemia

Akdim, F., Visser, M. E., Tribble, D. L., Baker, B. F., Stroes, E. S. G., Yu, R., Flaim, J. D., Su, J., Stein, E. A. & Kastelein, J. J. P., 2010, In: American journal of cardiology. 105, 10, p. 1413-1419

Research output: Contribution to journal › Article › Academic › peer-review